Lauren Mateja

SARS-CoV-2 mRNA Vaccines and Dermal Fillers: A Cause for Concern?
SARS-CoV-2 mRNA Vaccines and Dermal Fillers: A Cause for Concern?
02/16/2021
Dr Derek Jones explains how to handle patient questions regarding vaccination against COVID-19 in relation to their dermal fillers and appointments.
Dr Derek Jones explains how to handle patient questions regarding vaccination against COVID-19 in relation to their dermal fillers and appointments.
Dr Derek Jones explains how to...
02/16/2021
The Dermatologist
Eczema of the hand
FDA Alerts
Topical Ruxolitinib Gains FDA Approval for Atopic Dermatitis
09/21/2021
The FDA announced the approval of topical ruxolitinib for the treatment of atopic dermatitis in patients aged 12 years and older.
The FDA announced the approval of topical ruxolitinib for the treatment of atopic dermatitis in patients aged 12 years and older.
The FDA announced the approval...
09/21/2021
The Dermatologist
psoriasis elbow
FDA Alerts
Secukinumab Now Approved for Psoriatic Arthritis in Pediatric Patients
12/23/2021
The FDA announced that secukinumab received approval for the treatment of active psoriatic arthritis in patients aged 2 years and older.
The FDA announced that secukinumab received approval for the treatment of active psoriatic arthritis in patients aged 2 years and older.
The FDA announced that...
12/23/2021
The Dermatologist
FDA Alerts
Pembrolizumab Extends FDA Indication to Locally Advanced cSCC
07/07/2021
The FDA announced that it approved an expanded indication for pembrolizumab as monotherapy for the treatment of locally advanced cutaneous squamous cell carcinoma.
The FDA announced that it approved an expanded indication for pembrolizumab as monotherapy for the treatment of locally advanced cutaneous squamous cell carcinoma.
The FDA announced that it...
07/07/2021
The Dermatologist
Dr Ahmad Amin
Conference Coverage
Understanding Billing and Coding From the Provider’s Perspective
11/04/2021
Ahmad Amin, MD, shared what everyday dermatology providers need to know about the 2021 coding guidelines now that the updates have been out for approximately 1 year.
Ahmad Amin, MD, shared what everyday dermatology providers need to know about the 2021 coding guidelines now that the updates have been out for approximately 1 year.
Ahmad Amin, MD, shared what...
11/04/2021
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
The Growing Trend of Nonsurgical Body Contouring
Aesthetics Corner
The Growing Trend of Nonsurgical Body Contouring
02/13/2020
Cosmetic enhancements of the body were historically completed with invasive procedures that required significant recovery for sometimes underwhelming results. Adarsh Vijay Mudgil, MD, discussed the breakthroughs in cosmetic dermatology with...
Cosmetic enhancements of the body were historically completed with invasive procedures that required significant recovery for sometimes underwhelming results. Adarsh Vijay Mudgil, MD, discussed the breakthroughs in cosmetic dermatology with...
Cosmetic enhancements of the...
02/13/2020
The Dermatologist
Options With IL-23 Inhibitors for the Patient With Psoriasis
NPF Endorsed Features
Options With IL-23 Inhibitors for the Patient With Psoriasis
03/12/2020
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such...
03/12/2020
The Dermatologist
NPF Endorsed Features
IL-17 and Systemic Inflammation
12/08/2021
As the science continues to expand, psoriasis is now recognized as a whole-body disease. Understanding IL-17, a key player in systemic inflammation, has led to improvements in treating psoriasis.
As the science continues to expand, psoriasis is now recognized as a whole-body disease. Understanding IL-17, a key player in systemic inflammation, has led to improvements in treating psoriasis.
As the science continues to...
12/08/2021
The Dermatologist
severe eczema lichenification
FDA Alerts
FDA Approves Abrocitinib for Moderate to Severe AD
01/14/2022
Abrocitinib received FDA approval for the treatment of moderate to severe AD in adults whose disease was not adequately controlled with other systemic therapies.
Abrocitinib received FDA approval for the treatment of moderate to severe AD in adults whose disease was not adequately controlled with other systemic therapies.
Abrocitinib received FDA...
01/14/2022
The Dermatologist

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use